LAVA Therapeutics N.V.

General ticker "LVTX" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $36.0M (TTM average)

LAVA Therapeutics N.V. follows the US Stock Market performance with the rate: 31.7%.

Estimated limits based on current volatility of 0.9%: low 1.73$, high 1.76$

Factors to consider:

  • Earnings expected soon, date: 2025-12-09 bmo
  • Total employees count: 58 as of 2021
  • Earnings for 9 months up through Q3 are close to our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [0.72$, 1.95$]
  • 2025-12-31 to 2026-12-31 estimated range: [0.79$, 2.07$]

Financial Metrics affecting the LVTX estimates:

  • Positive: with PPE of -1.1 at the end of fiscal year the price was low
  • Negative: negative Operating income
  • Negative: Operating cash flow per share per price, % of -73.53 <= 0.33
  • Positive: 18.93 < Shareholder equity ratio, % of 34.32 <= 41.86
  • Positive: Inventory ratio change, % of -74.50 <= -0.75
  • Positive: Interest expense per share per price, % of 1.94 <= 3.41
  • Positive: Industry inventory ratio change (median), % of 0 <= 0

Similar symbols

Short-term LVTX quotes

Long-term LVTX plot with estimates

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue $19.39MM $6.77MM $11.98MM
Operating Expenses $54.23MM $50.16MM $41.67MM
Operating Income $-34.84MM $-43.39MM $-29.69MM
Non-Operating Income $3.18MM $1.78MM $5.21MM
Interest Expense $0.08MM $0.47MM $0.52MM
R&D Expense $40.10MM $32.56MM $28.45MM
Income(Loss) $-31.66MM $-41.61MM $-24.48MM
Taxes $0.25MM $0.26MM $0.63MM
Profit(Loss)* $-31.91MM $-41.87MM $-25.11MM
Stockholders Equity $86.04MM $51.18MM $27.75MM
Assets $143.43MM $101.71MM $80.83MM
Operating Cash Flow $4.04MM $-40.28MM $-19.54MM
Capital expenditure $0.59MM $0.73MM $0.02MM
Investing Cash Flow $9.35MM $-17.64MM $12.47MM
Financing Cash Flow $0.28MM $0.00MM $-0.57MM
Earnings Per Share** $-1.23 $-1.57 $-0.94

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.